
Toetal Solutions was granted FDA 510(k) clearance to market the Ziptoe Hammertoe System, an implant designed for proximal interphalangeal joint (PIPJ) arthrodesis in hammertoe correction procedures.
Ziptoe Hammertoe was developed to deliver consistent fixation while supporting efficient, repeatable surgical workflow. It addresses common challenges in hammertoe correction, including implant handling, alignment, and procedural simplicity by incorporating a pre-loaded titanium and nitinol intramedullary implant into a fully disposable surgical kit.
“Ziptoe was designed from day one to be a simple, repeatable, and effective solution to an indication that affects so many patients,” said Jeffrey F. O’Donnell, Jr., CEO of Toetal Solutions, Inc. “We are well-positioned with a regulatorily de-risked, strategically ready asset for the right partner that is looking to compete and win.”
Source: Toetal Solutions, Inc.
Toetal Solutions was granted FDA 510(k) clearance to market the Ziptoe Hammertoe System, an implant designed for proximal interphalangeal joint (PIPJ) arthrodesis in hammertoe correction procedures.
Ziptoe Hammertoe was developed to deliver consistent fixation while supporting efficient, repeatable surgical workflow. It addresses common...
Toetal Solutions was granted FDA 510(k) clearance to market the Ziptoe Hammertoe System, an implant designed for proximal interphalangeal joint (PIPJ) arthrodesis in hammertoe correction procedures.
Ziptoe Hammertoe was developed to deliver consistent fixation while supporting efficient, repeatable surgical workflow. It addresses common challenges in hammertoe correction, including implant handling, alignment, and procedural simplicity by incorporating a pre-loaded titanium and nitinol intramedullary implant into a fully disposable surgical kit.
“Ziptoe was designed from day one to be a simple, repeatable, and effective solution to an indication that affects so many patients,” said Jeffrey F. O’Donnell, Jr., CEO of Toetal Solutions, Inc. “We are well-positioned with a regulatorily de-risked, strategically ready asset for the right partner that is looking to compete and win.”
Source: Toetal Solutions, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





